Artificial Heart

This channel includes news and new technology innovations of artificial hearts. These technologies are used in cardiovascular surgery to temporarily or permanently replace the heart.

News | Artificial Heart | March 10, 2020

March 10, 2020 —  The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total...

News | Heart Failure | March 05, 2020

March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration...

he U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S. early feasibility study (EFS) of its total artificial heart.
News | Heart Failure | February 12, 2020

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device...

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. 

News | Atrial Fibrillation | May 13, 2019

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce...

Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018

December 11, 2018 — The scientific journal...

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

Feature | Heart Failure | October 19, 2018

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....

Technavio Market Study Shows Donor Shortage and Improved Survival Rate
News | Hemodynamic Support Devices | January 25, 2018

January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support...

CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device
News | Artificial Heart | December 11, 2017

December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life...

CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device
News | Artificial Heart | October 27, 2017

October 27, 2017 — CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its...

Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017

August 29, 2017 — Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full...

St. Jude Medical, HeartMate 3 LVAS, MOMENTUM 3 IDE study results, AHA Scientific Sessions 2016
News | Ventricular Assist Devices (VAD) | December 08, 2016

December 8, 2016 — St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-...

Syncardiac Freedom Driver, FDA
News | Artificial Heart | October 26, 2016

October 26, 2016 — The U.S. Food and Drug Administration (FDA) provided an update and additional information...

SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart | September 13, 2016

August 29, 2016 — SynCardia Systems, manufacturer of the...

Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart | September 09, 2016

September 9, 2016 — Carmat announced that the first implantation of its bioprosthetic...

SynCardia acquired, Versa Capital Management, chapter 11
News | Cardiovascular Business | July 07, 2016

July 7, 2016 — SynCardia Systems Inc. announced that it has entered into an...

Overlay Init